%0 Journal Article
%T Can we use biomarkers to identify those at risk of acute pain from sickle cell disease?
%A Bhat V
%A Sheehan VA
%J Expert Rev Hematol
%V 0
%N 0
%D 2024 Jul 5
%M 38949576
%F 2.819
%R 10.1080/17474086.2024.2372322
%X <B>UNASSIGNED: </B>Acute pain episodes, also known as vaso-occlusive crises (VOC), are a major symptom of sickle cell disease (SCD) and lead to frequent hospitalizations. The diagnosis of VOC can be challenging, particularly in adults with SCD, 50% of whom have chronic pain. Several potential biomarkers have been proposed for identifying individuals with VOC, including elevation above the baseline of various vascular growth factors, cytokines, and other markers of inflammation. However, none have been validated to date.<BR><B>UNASSIGNED: </B>We summarize prospective biomarkers for the diagnosis of acute pain in SCD, and how they may be involved in the pathophysiology of a VOC. Previous and current strategies for biomarker discovery, including the use of omics techniques, are discussed.<BR><B>UNASSIGNED: </B>Implementing a multi-omics-based approach will facilitate the discovery of objective and validated biomarkers for acute pain.